FORBES-TATE for EMERGENT BIOSOLUTIONS
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FY 2020 Appropriations - Provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Reauthorization of the Pandemic and All-Hazards Preparedness Act; NDAA - provisions related to biological and chemical defense; H.R. 2968/S. 2474 - Department of Defense Appropriations re Medical Countermeasures; FDA regulatory issues; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, Naloxone access, and co-prescribing/opioid prescribing guidelines; Issues related to FY 2020 Appropriations including: H.R. 3052/S. 2580 - Department of Interior, Environment, and Related Agencies Appropriations Act, 2020; H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 3164/S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY DRISCOLL | — |
| KRISTINA DUNKLIN | — |
| ELIZABETH GREER | — |
| RICK MURPHY | — |
| EDWARD C. RENO | — |
| JEFFREY SADOSKY | — |
| WESLEY RYAN WELCH | — |
| DERRICK M WHITE | — |
| ZACHARY WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.